National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$59.95
add to cart

HARDBACK
price:$79.95
add to cart

Rights & Permissions

topleft topright

Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc (2001)
Food and Nutrition Board (FNB)
Institute of Medicine (IOM)

Citation Manager

. "10 Manganese." Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: The National Academies Press, 2001.

Please select a format:

BibTeX EndNote RefMan


Page
409
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc

Hazard Identification

Adverse Effects

Manganese toxicity in humans is a well-recognized occupational hazard for people who inhale manganese dust. The most prominent effect is central nervous system pathology, especially in the extra-pyramidal motor system. The lesions and symptoms are similar to those of Parkinson’s disease (Barceloux, 1999; Keen et al., 1994). Manganese is probably transported into the brain via transferrin (Aschner et al., 1999). These authors hypothesize that the greater vulnerability of the extrapyramidal system (globus pallidus and substantia nigra) for manganese accumulation could be due to the fact that these are areas that are efferent to areas of high transferrin receptor density. These same efferent areas are also regions of high iron content.

Neurotoxicity of orally ingested manganese at relatively low doses is more controversial. However, several lines of evidence suggest this possibility. The data on manganese neurotoxicity are reviewed below.

Elevated Blood Manganese and Neurotoxicity. People with chronic liver disease have neurological pathology and behavioral signs of manganese neurotoxicity, probably because elimination of manganese in bile is impaired (Butterworth et al., 1995; Hauser et al., 1994; Spahr et al., 1996). This impairment results in higher circulating concentrations of manganese, which then has access to the brain via transferrin. Hauser and coworkers (1994) reported whole blood manganese concentrations of 18.8 to 45 μg/L in three patients with chronic liver disease, as compared to a normal range of 4.2 to 14.3 μg/L. Spahr and coworkers (1996) reported blood manganese concentrations of 124.7 nmol/L (6.85 μg/L) in control subjects versus 331.4 nmol/L (18.2 μg/L) in patients with cirrhosis. High concentrations of circulating manganese as a result of total parenteral nutrition have also been associated with manganese toxicity (Keen et al., 1999). Davis and Greger (1992) reported that women who ingested 15 mg/day of supplemental manganese had serum manganese concentrations that increased gradually throughout the 125-day study; significant differences were reported after 25 days of supplementation.

Neurotoxicity in Laboratory Animals. High subchronic or chronic doses of manganese given to animals in food or water result in

Page
409
Front Matter (R1-R24)
Summary (1-28)
1 Introduction to Dietary Reference Intakes (29-43)
2 Overview and Methods (44-59)
3 A Model for the Development of Tolerable Upper Intake Levels (60-81)
4 Vitamin A (82-161)
5 Vitamin K (162-196)
6 Chromium (197-223)
7 Copper (224-257)
8 Iodine (258-289)
9 Iron (290-393)
10 Manganese (394-419)
11 Molybdenum (420-441)
12 Zinc (442-501)
13 Arsenic, Boron, Nickel, Silicon, and Vanadium (502-553)
14 Uses of Dietary Reference Intakes (554-579)
15 A Research Agenda (580-586)
Appendix A Origin and Framework of the Development of Dietary Reference Intake (587-590)
Appendix B Acknowledgments (591-593)
Appendix C Dietary Intake Data from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 (594-643)
Appendix D Dietary Intake Data from the Continuing Survey of Food Intakes by Individuals (CSFII), 1994-1996 (644-653)
Appendix E Dietary Intake Data from the U.S. Food and Drug Administration Total Diet Study, 1991-1997 (654-673)
Appendix F Canadian Dietary Intake Data, 1990 (674-679)
Appendix G Biochemical Indicators for Iron, Vitamin A, and Iodine from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 (680-691)
Appendix H Comparison of Vitamin A and Iron Intake and Biochemical Indicators from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 (692-696)
Appendix I Iron Intakes and Estimated Percentile of the Distribution of Iron Requirements from the Continuing Survey of Food Intakes by Individuals (CSFII), 1994-1996 (697-703)
Appendix J Glossary and Acronyms (704-708)
Appendix K Conversion of Units (709-709)
Appendix L Options for Dealing with Uncertainties (710-714)
Appendix M Biographical Sketches of Panel and Subcommittee Members (715-728)
Index (729-769)
Summary Table, Dietary Reference Intakes: Recommended Intakes for Individuals, Vitamins (770-771)
Summary Table, Dietary Reference Intakes: Recommended Intakes for Individuals, Elements (772-773)